
CE-245677
CAS No. 717899-97-3
CE-245677 ( CE245677 )
产品货号. M15745 CAS No. 717899-97-3
CE-245677 是一种有效、选择性、口服活性、双重 Tie2/Trk 激酶抑制剂,对于 Tie2 和 TrkA/B 的 IC50 分别为 4.7 nM、1 nM。
纯度: >98% (HPLC)






规格 | 价格/人民币 | 库存 | 数量 |
2MG | ¥640 | 有现货 |
![]() ![]() |
5MG | ¥988 | 有现货 |
![]() ![]() |
10MG | ¥1596 | 有现货 |
![]() ![]() |
25MG | ¥2665 | 有现货 |
![]() ![]() |
50MG | ¥3686 | 有现货 |
![]() ![]() |
100MG | ¥5443 | 有现货 |
![]() ![]() |
200MG | 获取报价 | 有现货 |
![]() ![]() |
500MG | 获取报价 | 有现货 |
![]() ![]() |
1G | 获取报价 | 有现货 |
![]() ![]() |
生物学信息
-
产品名称CE-245677
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述CE-245677 是一种有效、选择性、口服活性、双重 Tie2/Trk 激酶抑制剂,对于 Tie2 和 TrkA/B 的 IC50 分别为 4.7 nM、1 nM。
-
产品描述CE-245677 is a potent, selective, orally active, dual Tie2/Trk kinase inhibitor with IC50 of 4.7 nM, 1 nM for Tie2 and TrkA/B, respectively; displays >100-fold selectivity against a panel of angiogenic receptor tyrosine kinases (e.g. KDR, PDGFR, FGFR).Pain Phase 1 Clinical.
-
体外实验CE-245677 is a potent reversible inhibitor of Tie2 and TrkA/B kinases with a cellular IC50 of 4.7 and 1 nM, and displays >100x selectivity against a number of other angiogenic receptor tyrosine kinases, such as KDR, PDGFR, FGFR.
-
体内实验CE-245677 shows good oral absorption in in vivo rat PK studies (F=80%).
-
同义词CE245677
-
通路Tyrosine Kinase
-
靶点Angiopoietin Receptor
-
受体Angiopoietin Receptor
-
研究领域Neurological Disease
-
适应症Pain
化学信息
-
CAS Number717899-97-3
-
分子量513.379
-
分子式C24H22Cl2N6O3
-
纯度>98% (HPLC)
-
溶解度In Vitro:?DMSO : 125 mg/mL (243.48 mM)
-
SMILESO=C(NC1=CC=C(Cl)C=C1Cl)NC2=CC(C(C3=CN(C(C)C)C4=NC=NC(N)=C43)=O)=CC=C2OC
-
化学全称1-(5-(4-amino-7-isopropyl-7H-pyrrolo[2,3-d]-pyrimidine-5-carbonyl)-2-methoxyphenyl)-3-(2,4-dichlorophenyl)urea
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Susan LaGreca, et al. Identification of selective, orally active Tie2 kinase inhibitors and discovery of CE-245,677 and PF-371,989. AACR Annual Meeting-Apr 14-18, 2007.